医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Notice Regarding Commencement of Tender Offer for Benesse Holdings, Inc. (Securities Code: 9783) by Bloom 1 K.K.

2024年01月29日 PM05:15
このエントリーをはてなブックマークに追加


 

TOKYO

We hereby announce today that the attached press release issued by Bloom 1 K.K. titled “Notice Regarding Commencement of Tender Offer for Benesse Holdings, Inc. (Securities Code: 9783)” has been released.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240126441982/en/

This material is published pursuant to Article 30, Paragraph 1, Item 4 of the Order for Enforcement of the Financial Instruments and Exchange Act at the request of Bloom 1 K.K. (the Offeror) to Benesse Holdings, Inc. (the Target Company of the Tender Offer).

(Attachment)
Notice Regarding Commencement of Tender Offer for Benesse Holdings, Inc. (Securities Code: 9783) dated January 29, 2024

View source version on businesswire.com: https://www.businesswire.com/news/home/20240126441982/en/

CONTACT

KRIK (PR Agent)

Koshida: +81-70-8793-3990

Sugiyama: +81-70-8793-3989

同じカテゴリーの記事 

  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
  • ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market